30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Holding Companies

Achilles Therapeutics PLC (ACHL)

Track

Stock chart
Ticker: ACHL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Coutts Robert William
Officer
1 sale — total 5,006 USD
Proposed sale 3 Mar 2025
Value US$4,620,679.21 | Price 456.70 | Shares 48,760
Proposed sale 3 Mar 2025
Value US$4,136,016.34 | Price 29.20 | Shares 66,388
Proposed sale 13 Feb 2025
Value US$354.56 | Price 1.06 | Shares 334
Proposed sale 6 Feb 2025
Value US$53,537.00 | Price 1.38 | Shares 38,750
Proposed sale 6 Feb 2025
Value US$34,500.00 | Price 1.38 | Shares 25,000
Proposed sale 5 Feb 2025
Value US$91,956.43 | Price 1.23 | Shares 75,024
Proposed sale 4 Feb 2025
Value US$34,815.25 | Price 1.39 | Shares 25,000
Proposed sale 4 Feb 2025
Value US$34,003.80 | Price 1.36 | Shares 25,000
Proposed sale 4 Feb 2025
Value US$18,857.00 | Price 1.37 | Shares 13,750
Proposed sale 4 Feb 2025
Value US$34,250.00 | Price 1.37 | Shares 25,000
Proposed sale 4 Feb 2025
Value US$291.81 | Price 1.19 | Shares 246
Proposed sale 4 Feb 2025
Value US$80,620.86 | Price 1.17 | Shares 68,814
Proposed sale 4 Feb 2025
Value US$64,336.57 | Price 1.29 | Shares 50,000
Proposed sale 4 Feb 2025
Value US$64,452.61 | Price 1.29 | Shares 50,000
Proposed sale 4 Feb 2025
Value US$92,265.37 | Price 1.37 | Shares 67,437
Proposed sale 1 Feb 2024
Value US$27,900.00 | Price 0.93 | Shares 30,000
Proposed sale 1 Nov 2023
Value US$30,100.00 | Price 0.86 | Shares 35,000
Proposed sale 17 Aug 2023
Value US$32,735.00 | Price 0.94 | Shares 35,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-03-03 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
48,760
456.70
US$4,620,679 		48,760 456.70 US$4,620,679
2025-03-03 2025-03-03 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
66,388
29.20
US$4,136,016 		66,388 29.20 US$4,136,016
2025-02-18 2025-02-13 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
83,617
96.92
US$574,033 		83,617 96.92 US$574,033
2025-02-11 2025-02-06 PrS Proposed sale
Ehmer Bernhard

Director; Former Director

Non-Executive Director
38,750
1.38
US$53,537 		38,750 1.38 US$53,537
2025-02-07 2025-02-06 PrS Proposed sale
Moses Edwin

Director

Non-Executive Director
25,000
1.38
US$34,500 		25,000 1.38 US$34,500
2025-02-05 2025-02-05 PrS Proposed sale
2.0
Coutts Robert William

Officer

Officer
75,024
1.23
US$91,956 		75,024 1.23 US$91,956
2025-02-06 2025-02-04 PrS Proposed sale
3.0
Giordano Michael F

Former Director

Non-Executive Director
25,000
1.39
US$34,815 		25,000 1.39 US$34,815
2025-02-06 2025-02-04 PrS Proposed sale
BOESS CARSTEN

Director

Non-Executive Director
25,000
1.36
US$34,004 		25,000 1.36 US$34,004
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
13,750
1.37
US$18,857 		13,750 1.37 US$18,857
2025-02-06 2025-02-04 PrS Proposed sale
O'Neill Julie

Former Director

Non-Executive Director
25,000
1.37
US$34,250 		25,000 1.37 US$34,250
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
246
1.19
US$292 		246 1.19 US$292
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
68,814
1.17
US$80,621 		68,814 1.17 US$80,621
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,337 		50,000 1.29 US$64,337
2025-02-06 2025-02-04 PrS Proposed sale
Ali Iraj

Director

Non-Executive Director
50,000
1.29
US$64,453 		50,000 1.29 US$64,453
2025-02-05 2025-02-04 PrS Proposed sale
Quezada Sergio Andres

Former Officer

Officer
67,437
1.37
US$92,265 		67,437 1.37 US$92,265
2024-02-01 2024-02-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
30,000
0.93
US$27,900 		30,000 0.93 US$27,900
2023-11-01 2023-11-01 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.86
US$30,100 		35,000 0.86 US$30,100
2023-08-17 2023-08-17 PrS Proposed sale
Peggs Karl Stuart Dr

Officer

Officer
35,000
0.94
US$32,735 		35,000 0.94 US$32,735
Explore more

More insider trading research around Achilles Therapeutics PLC

More insider trades in United Kingdom
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in Europe